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Most cancer patients in westernised countries now want all information about their situation, good or bad, and many wish to be
involved in decision-making. The attitudes to and use of shared decision-making (SDM) by cancer doctors is not well known.
Australian cancer clinicians treating breast, colorectal, gynaecological, haematological, or urological cancer were surveyed to identify
their usual approach to decision-making and their comfort with different decision-making styles when discussing treatment with
patients. A response rate of 59% resulted in 624 complete surveys, which explored usual practice in discussing participation in
decision-making, providing information, and perception of the role patients want to play. Univariate and multivariate analyses were
performed to identify predictors of use of SDM. Most cancer doctors (62.4%) reported using SDM and being most comfortable with
this approach. Differences were apparent between reported high comfort with SDM and less frequent usual practice. Multivariate
analysis showed that specialisation in breast or urological cancers compared to other cancers (AOR 3.02), high caseload of new
patients per month (AOR 2.81) and female gender (AOR 1.87) were each independently associated with increased likelihood of use
of SDM. Barriers exist to the application of SDM by doctors according to clinical situation and clinician characteristics.
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Shared decision-making (SDM) is perceived by many as the
preferred way for health professionals and patients to approach
treatment decisions. Public expectation to be fully informed about
healthcare and available options has increased over recent years
and there is decreasing acceptance of paternalism, highlighted in
references to patients as consumers in the medical ethics and
healthcare literature (Shotton, 1997). Meeting the involvement
preferences of patients has positive effects on outcomes such as
increased patient satisfaction and reduced decisional conflict and
improved concordance with treatment regimens (Anderson et al,
1995; Jahng et al, 2005).
Shared decision-making lies between paternalism and informed
decision-making and can be considered an important component
of patient-centred care (Edwards et al, 2003). Shared decision-
making involves two steps: presentation of facts about treatment
options and discussion of preferences, with the doctor’s and
patient’s values together determining the final decision (Eddy,
1990). The challenges for the clinician are to minimise patients’
misunderstanding and misinterpretation of risks or benefits of
treatment and to avoid imposing his or her own treatment
preferences onto the patient.
From the clinician’s perspective, SDM is a useful way of presenting
to patients the reality that outcomes in medicine are not certain.
Shared decision-making is particularly appropriate in instances where
there is more than one clinically reasonable treatment option or
where there is a reasonable degree of uncertainty in the outcome of a
particular intervention (Whitney et al, 2003; Kaplan, 2004).
The literature suggests that SDM is not always achieved,
although it is not clear whether patient or doctor barriers are
more important. The preferences of cancer patients in this area
have been widely studied (Say et al, 2006) but information is
limited on the attitudes and practise of cancer clinicians when
discussing treatments.
We surveyed cancer clinicians across Australia from August
2004 to May 2006 to document their views on SDM and discover
whether their views differed systematically according to doctor
characteristics. We aimed to gain an expansive understanding of
use and support of the different approaches to decision-making
when discussing treatment options and did not identify particular
clinical situations in the survey instrument. We hypothesised that
certain factors may influence the support and use of SDM such as
doctor specialty, clinician practice, practice setting, and patient
caseload. As younger doctors have been educated in evidence-
based medicine and during the rise of medical consumerism, we
also expected more positive attitudes to SDM in this age group.
Other doctor characteristics might also influence attitudes and
practise. Because of reduced access to some treatments and
therefore reduced choice for patients in rural areas, we thought
that doctors practising in rural communities might favour a SDM
approach less than their colleagues in urban practices.
MATERIALS AND METHODS
Participants
Medical and radiation oncologists and surgeons practising mainly
in oncology across Australia specialising in managing people with
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sfive tumour types (breast, colorectal, gynaecological, haematolo-
gical, or urological cancers) were invited to participate in the
study. Doctors were identified through the Australia and New
Zealand Breast Cancer Trials Group, the Royal Australian College
of Surgeons – Breast Section, the Medical Oncology Group of
Australia, the Colorectal Surgical Society of Australasia, Australian
Society of Gynaecologic Oncologists, the Australasian Leukaemia
and Lymphoma Group, and the Urological Society of Australasia.
The invitation letter clearly stated the intended participants as
cancer doctors. Doctors who had retired from active practice were
excluded from the study.
Questionnaire
The survey instrument was based on a structured questionnaire
developed by Charles et al (2003, 2004) in Ontario, Canada in 1998
through a process of focus groups and pilot-testing. With
permission, we used this questionnaire with some alterations.
The survey presented unlabelled examples constructed from the
conceptual framework presented by Charles et al (1997, 1999)in
earlier publications to reflect the following decision-making
approaches: paternalistic, information-sharing only, informed,
and shared (see Figure 1). Doctors were asked to select which of
the examples best reflected their usual approach to treatment
decision-making with their newly diagnosed or newly referred
patients. Doctors were asked to rate their comfort levels with each
of the decision-making approaches on a five-point Likert scale,
from not comfortable to extremely comfortable. Doctors also
indicated with what percentage of their patients they usually
initiated a discussion concerning participation in decision-making,
whether they routinely offered a treatment recommendation, and
which role they felt their patients wanted to play: passive, shared,
or active. Finally, doctors indicated the amount of detail they
usually provide from 1¼no information to 5¼a great deal of
information on 10 topics related to the benefits and costs of
treatment options.
Design and procedures
This was a cross-sectional survey. Permission was sought to obtain
contact details of all group members from each representative
body. If this was granted, the research team sent each doctor a
package through the mail which included a letter inviting their
participation and outlining that the survey intended to compare
views of cancer doctors, an information sheet, a consent form, a
copy of the questionnaire, and postage-paid envelope. If contact
details were not provided, the packages were distributed by the
representative body. Written endorsement of the survey was
sought and obtained from representative bodies. Reminders were
dispatched at 6 and 12 weeks if no response had been received. A
modified approach by Dillman (1978) was used to follow up
invited participants. The second contact was by mail and
comprised a letter reminding the participant of the questionnaire
and the value their input would bring to the study. The third and
final contact included a second copy of the questionnaire with a
return envelope, a letter outlining the aims of the survey, and a
further reminder of the importance of their contribution and the
proportion of completed surveys that had been received so far. The
returned surveys were anonymous.
Data analysis
Demographics and characteristics of the sample were analysed
using descriptive statistics. Univariate analysis was completed to
identify associations between variables and usual approach to
decision-making and high comfort with SDM. Logistic regression
analyses were completed with usual approach, recoded as
shared or not, and with comfort, recoded as low or high, as the
dependent variables in multivariate analysis to identify predictors
of use of and comfort with SDM. Covariates for initial inclusion
into the model were identified through univariate analysis
(Pp0.25). To identify the final predictive factors for retention in
the model, we applied multivariable logistic regression analysis.
We used the likelihood ratio test in a backwards elimination
process, with Po0.05 for a covariate to be retained in the final
model. Model fit was assessed with Hosmer–Lemeshow goodness
of fit w
2 tests. All analyses were performed using SPSS for Windows
Version 14.
RESULTS
Participants
Of 1198 total surveys mailed, 136 were returned and regarded as
being ineligible (doctor retired, deceased, not clinically active,
overseas, and incorrect address). From the remaining 1062 eligible
participants, 632 surveys were returned, a response rate of 59%.
Eight respondents declined to participate. Twenty of the surveys
were completed by clinicians who reported that they did not treat
patients in the five targeted tumour groups; therefore, these data
were excluded from statistical analysis. The response rate was
higher in the groups where the researchers contacted the
participants directly, perhaps because the mailing list being used
by the professional society did not exclude retired or non-
practising doctors. Within the non-respondents, tumour special-
ties were breast 30%, colorectal 10%, gynaecological 2%,
haematological 9%, urological 42% and 7% unknown. The high
non-responders in the urological cohort may reflect the mail out
method in this group. Excluding the urological cohort on whom we
had no information, 89% of the non-responders were male.
Comparison of these characteristics with the study sample reveals
no notable differences.
Table 1 shows the demographics of the 604 participating
clinicians. Males (83.3%) made up the larger proportion of the
sample. Mean age of the sample was 50 years and mean number of
years medically qualified was 26 years. The majority (68.8%)
worked 420h per week in direct patient care. The majority
(58.7%) worked in community sizes of 4500000.
Example 1 Paternalistic 
After reviewing the medical records and examining the patient, the doctor 
decides on a suitable treatment and presents this to the patient.  The doctor
gives information about the treatment including risks and benefits. The patient 
accepts the treatment that the doctor recommends.
Example 2 Information sharing only 
After reviewing the medical records and examining the patient, the doctor 
presents the available treatment options.  Information about the risks and 
benefits of each option are given and discussed with the patient.  The doctor 
then recommends a treatment that the patient accepts.
Example 3 Informed 
After reviewing the medical records and examining the patient, the doctor 
presents the available treatment options.  Information about the risks and 
benefits of each option are given and discussed with the patient.  The doctor 
asks the patient to decide on a treatment and states that she/he is the best 
person to make the decision.  The patient decides and informs the doctor of the 
treatment s/he prefers.
Example 4 Shared 
After reviewing the medical records and examining the patient, the doctor 
presents the available treatment options.  Information about the risks and 
benefits of each option are given and discussed with the patient.  The doctor 
invites the patient to ask any questions.  The doctor asks what his/her 
preferences for treatment are given his/her lifestyle and the issues that are 
important to him/her. Together they decide on a suitable treatment to 
implement.
Figure 1 Treatment decision-making examples.
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The majority reported that their usual approach to decision-
making with cancer patients was most like the SDM approach (see
Table 2). The paternalistic approach and the informed decision-
making approach were selected by fewer doctors.
Most doctors (82.1%) reported initiating a discussion about
participating in decision-making with their patients; however, only
62.5% instigated this dialogue with more than half of their patients.
Offering treatment options when available was almost unan-
imously supported (98.5%).
Comfort with different approaches to decision-making
Comfort levels with each of the four decision-making approaches
are shown in Table 2. The model with which most doctors (59.7%)
reported being most comfortable was the SDM approach; 37.1%
reported being least comfortable with the paternalistic model.
Information giving
The amount and type of information doctors routinely gave to
newly diagnosed or newly referred patients varied according to
specialty (Table 3). Items that doctors gave the most information
about were extent of disease, treatment procedures, and benefits
and risks. Items about which doctors gave the least information
were effects of treatment on family, sexuality, and mood. The
amount of information given was scored out of 50; the mean score
was 37.38, s.d. 5.372.
Comparing the mean scores of amount of information given by
clinicians according to their usual approach to decision-making
revealed that doctors using SDM gave significantly more informa-
tion (mean score 38.27) than doctors who reported not using SDM
(mean 35.86), P¼0.00.
Clinician perception of patient role preference
Forty-five per cent of doctors reported that more than half of their
patients preferred to share decision-making responsibility with
their doctors (see Table 4). When this response was examined by
specialty and doctor discipline, significantly more urological
(55.1%) and breast (53.4%) cancer doctors reported that more
than half of their patients wanted to share responsibility (P¼0.00,
d.f.¼4, OR¼42.35). Significantly more medical oncologists
(P¼0.00, d.f.¼4, OR¼32.94) than other disciplines reported that
more than half of their patients wanted to share decision-making
responsibility. The other disciplines stated that the majority of
their patients wanted the doctor to take the decision-making
responsibility. Very few clinicians (o10%) felt that the majority of
their patients wanted to take the lead in this process.
Predictors of usual approach to decision-making
The original four category response to usual approach to decision-
making was collapsed into two categories; SDM or not. This
decision was taken as only example 4 describes SDM fully,
incorporating sharing of decision-making responsibility, encour-
agement of patient involvement, and discussion of patient
preferences and values relevant to the situation.
We analysed the data using crosstabs and w
2 to identify
significant predictors of usual approach to decision-making.
Univariate analysis results are presented in Table 5.
More medical oncologists (66.1%) and surgeons (66.2%)
reported using a shared approach than other doctors. The duration
of direct patient care per week and the size of the community in
which the doctors practised did not influence the approach to
treatment decision-making. More doctors specialising in breast or
urological cancer reported using a shared approach than doctors
specialising in colorectal, gynaecological, or haematological
cancer. To further explore these results, we grouped the clinicians
into those treating cancers with well-known preference-sensitive
decisions and those where there are not. Breast and urology cancer
doctors (prostate cancer) were combined to form the preference
sensitive group (n¼415) and colorectal, gynaecological, and
leukaemia/lymphoma doctors were grouped as the non-preference
sensitive group (n¼189). This variable was included in the
multivariate analysis reported below.
We performed binary logistic regression of usual approach to
decision-making (shared or non-shared) using independent
variables with w
2 of o0.25. Variables entered in the model were
cancer type (breast and urological doctors vs colorectal, gynaeco-
logical, and haematological doctors, gender, age (three groups),
new patient caseload per month (2 or less, 3–6, 7–10, or 411),
and country of medical training (Australia vs elsewhere). We used
Table 1 Demographics of sample
Variable N (%)
a
Cancer type
Breast 308 (51.0)
Colorectal 79 (13.1)
Gynaecological 27 (4.5)
Leukaemia/lymphoma 83 (13.7)
Urological 107 (17.7)
Doctor type
Medical oncologist 126 (20.9)
Radiation oncologist 51 (8.4)
Surgeon 354 (58.6)
Haematologist 61 (10.1)
Paediatric oncologist 12 (2.0)
Gender
Male 544 (83.3)
Female 101 (16.7)
Medical training
Australia 544 (90.4)
Other 58 (9.6)
Direct patient care per week
o20h 170 (31.2)
20h or more 375 (68.8)
Main place of clinical work
Private hospital 217 (39.8)
Public hospital 165 (30.3)
Cancer centre 43 (7.9)
University affiliated 8 (1.5)
Public/private 50/50 111 (20.4)
Other 1 (0.2)
Community size
o100000 41 (7.5)
100000–500000 184 (33.8)
4500000 319 (58.7)
Caseload of new patients per month
b
2 or less 81 (13.5)
3–6 232 (38.8)
7–10 147 (24.6)
11–15 69 (11.5)
16–20 37 (6.2)
21+ 32 (5.4)
Median 3–6 new patients per month
Age (mean) 50 years (32–79 years)
Years qualified (mean) 26 years (4–56 years)
aPercentages based on valid cases only.
bWith specified cancer.
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sa backward stepwise likelihood ratio model; non-shared was the
reference category of the dependent variable. The final model has a
w
2 of 51.31, d.f.¼5, P¼0.00. Goodness of fit is supported by the
Hosmer–Lemeshow test; w
2 4.62, d.f.¼7, P¼0.71.
Doctors practising in breast or urological cancer were three
times as likely to use a shared approach compared to colorectal,
gynaecological, or haematological doctors (Po0.001, OR¼3.02,
95% CI 2.08–4.37). Doctors reporting the highest numbers of new
patients per month had 2.8 times the odds of using a shared
approach (Po0.005, OR¼2.81, 95% CI 1.54–5.16). Female doctors
had 1.9 times the odds of using shared approach compared to their
male colleagues (Po0.001, OR¼1.87, 95% CI 1.13–3.10). Vari-
ables not independently associated with usual approach to
decision-making were country of medical training and age (see
Table 6).
Predictors of comfort with SDM
Univariate analysis was undertaken for high comfort with the SDM
(see Table 7). Shared decision-making was rated with the highest
comfort levels by doctors treating breast or urological cancers
(87.6%). Medical (89.0%) and radiation oncologists (78%) and
surgeons (84.3%) reported being most comfortable with the shared
approach.
We performed binary logistic regression of comfort with SDM
(low comfort or high comfort) using independent variables with w
2
of o0.25. Variables entered in the model were cancer type (breast
and urological doctors vs colorectal, gynaecological, and haema-
tological doctors), doctor gender, and new patient caseload per
month. We used a backward stepwise likelihood ratio model; low
comfort was the reference category of the dependent variable. The
Table 2 Usual approach to decision-making and comfort levels with each approach
Usual approach
N (%)
Not comfortable
N (%)
Somewhat comfortable
N (%)
Neutral
N (%)
Very comfortable
N (%)
Extremely
comfortable N (%)
Paternalistic (example 1) 6 (1.0) 198 (37.1) 144 (27.0) 85 (15.9) 60 (11.3) 46 (8.6)
Information sharing (example 2) 138 (23.2) 39 (7.3) 95 (17.8) 135 (25.3) 154 (28.9) 110 (20.6)
Informed (example 3) 49 (8.2) 73 (13.7) 118 (22.1) 115 (21.5) 145 (27.2) 83 (15.5)
Shared (example 4) 372 (62.4) 11 (2.1) 23 (4.3) 49 (9.1) 133 (24.8) 320 (59.7)
None of these 1 (0.2)
Other 30 (5.0)
Table 3 Amount of information given to new patients
No
information
N (%)
A little
information
N (%)
Some
information
N (%)
Quite a bit of
information
N (%)
Great deal of
information
N (%) Mean (s.d.)
Extent of the disease 1 (0.2) 4 (0.7) 37 (6.2) 233 (38.8) 326 (54.2) 4.46 (0.658)
Details of treatment procedures 1 (0.2) 0 (0) 22 (3.7) 193 (32.1) 385 (64.1) 4.60 (0.578)
Benefits of treatment 1 (0.2) 0 (0) 18 (3.0) 234 (39.1) 346 (57.8) 4.54 (0.573)
Risks (side effects) of treatment 1 (0.2) 2 (0.3) 36 (6.0) 237 (39.5) 324 (54.0) 4.47 (0.640)
Impact of treatment on sexuality 34 (5.7) 128 (21.4) 189 (31.6) 136 (22.7) 111 (18.6) 3.27 (1.158)
Changes in appearance due to treatment 22 (3.7) 63 (10.5) 197 (32.9) 218 (36.4) 99 (16.5) 3.52 (1.006)
Effects of treatment on mood 41 (6.8) 135 (22.5) 247 (41.1) 133 (22.1) 45 (7.5) 3.01 (1.010)
Effects of treatment on family 51 (8.5) 179 (29.8) 223 (37.1) 107 (17.8) 41 (6.8) 2.85 (1.033)
Effects of treatment on social activities 22 (3.7) 114 (19.0) 233 (38.8) 178 (29.7) 53 (8.8) 3.21 (0.972)
Effects of treatment on patients’ ability to care for
themselves at home
15 (2.5) 72 (12.0) 194 (32.4) 229 (38.2) 89 (14.9) 3.51 (0.969)
Total information giving score 37.38 (5.372)
Table 4 Perception of patient preferred role
Doctor takes full
responsibility N (%)
a
Share responsibility
N (%)
a
Patient takes full
responsibility N (%)
a v
2 (d.f.)
Cancer specialty w
2(4)¼17.16**
Breast 80 (26.8) 159 (53.4) 4 (1.3)
Colorectal 41 (52.6) 26 (33.3) 1 (1.3)
Leukaemia/lymphoma 43 (53.8) 18 (22.5) 1 (1.3)
Gynaecological 16 (61.5) 5 (19.2) 0 (0.0)
Urological 22 (20.6) 59 (55.1) 2 (1.9)
Doctor type w
2(4)¼31.13**
Medical oncologists 29 (24.2) 70 (58.3) 2 (1.7
Radiation oncologists 22 (44.0) 15 (30.0) 0 (0.0)
Haematologists 31 (52.5) 11 (18.6) 0 (0.0)
Paediatric oncologists 5 (45.5) 4 (36.4) 1 (9.1)
Surgeons 115 (33.0) 167 (47.9) 5 (1.4)
d.f.¼degrees of freedom. **Po0.01.
a% of doctors who reported the role 450% of their patients preferred.
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2 of 23.55, d.f.¼5, P¼0.00. Goodness of fit is
supported by the Hosmer–Lemeshow test; w
2 10.55, d.f.¼6,
P¼0.10.
In multivariate regression analysis, doctors practising in breast
or urological cancer were 21
2 times as likely to be very comfortable
with SDM compared to colorectal, gynaecological, or haematolo-
gical doctors (Po0.001, OR¼2.53, 95% CI 1.52–4.24). Female
doctors had 2.3 times the odds of being very comfortable with
SDM compared to their male counterparts (Po0.05, OR¼2.31,
95% CI 1.01–5.27). Overall caseload did not produce a significant
result; however, doctors reporting the highest numbers of new
patients per month showed 2.3 times the odds of being very
comfortable using SDM (P¼0.05, OR¼2.33, 95% CI 0.10–5.44)
(see Table 8).
Our results show a discrepancy between reported usual practice
of SDM and high comfort with that approach. This mismatch is
highest in the gynaecological doctors (48.2%) (see Table 9).
DISCUSSION
We investigated usual practice and comfort levels with treatment
decision-making across cancer care in Australia. Our expectation
that differences would exist between tumour specialties and
between doctor disciplines was supported. Since a clear treatment
choice is available in the management of early breast cancer and
because of the breast cancer consumer movement, we expected
more positive attitudes to SDM to be evident in surgeons treating
this disease. Demographic differences were apparent in Australian
clinicians’ approach to decision-making, not only in their usual
practice but also in their comfort with the styles presented in the
survey.
Comfort with and use of SDM
Respondents reported high levels of comfort with SDM and
discomfort with a paternalistic model. These results reflect the
changes over recent years in the expectations and information
preferences of patients and suggest that clinicians are responding
to an increasingly consumerist model of healthcare. A UK study
that used focus group interviews with general practitioners also
reported positive attitudes to patient involvement (Elwyn et al,
2000). Doctor use of SDM in our survey was associated with
reported greater information giving compared to colleagues who
did not use a shared approach.
Our hypothesis that doctors treating breast cancer would
involve patients in decision-making was supported. Breast cancer
doctors in Australia strongly endorsed SDM as found in Canada
(Charles et al, 2004). Indeed there were strong similarities between
the decision-making practices of Australian and Canadian breast
cancer doctors (Charles et al, 2004), suggesting a similar culture
surrounding treatment decision-making in the two countries.
Shared decision-making was also strongly supported by the
urological specialists. Conversely, support for SDM was low in
paediatric oncologists and haematologists. Paediatricians may feel
that parents of seriously ill children need to be informed of
options, but led to the preferred treatment because of the
extremely emotional context. Other clinicians, however, may feel
more able to share decision-making where a treatment decision is
Table 5 Univariate analyses of usual DM approach by doctor
characteristics
Non-shared
N (%)
Shared
N (%) v (d.f.)
Doctor type
Medical oncologists 42 (33.9) 82 (66.1) w
2(4)¼15.240**
Radiation oncologists 24 (48.0) 26 (52.0)
Surgeons 118 (33.8) 231 (66.2)
Haematologists 32 (52.5) 29 (47.5)
Paediatric oncologists 8 (66.7) 4 (33.3)
Tumour type
Breast 99 (32.9) 202 (67.1) w
2(4)¼37.256**
Colorectal 42 (53.8) 36 (46.2)
Leukaemia/lymphoma 44 (53.0) 39 (47.0)
Gynaecological 16 (59.3) 11 (40.7)
Urological 23 (21.5) 84 (78.5)
Cancer specialty
Breast and urological 122 (29.9) 286 (70.1) w
2(1)¼32.538**
Colorectal, gynaecology,
and haematology
102 (54.3) 86 (45.7)
Gender
Male 198 (39.9) 298 (60.1) w
2(1)¼6.873**
Female 26 (26.0) 74 (74.0)
Age
Under 40 years 25 (29.4) 60 (70.6) w
2(2)¼2.802
40–55 years 125 (39.2) 194 (60.8)
Over 55 years 73 (38.2) 118 (61.8)
Country of medical training
Australia 195(36.4) 341 (63.6) w
2(1)¼2.313
Other 27(46.6) 31 (53.4)
New patient caseload per month
2 or less 38 (47.5) 42 (52.5) w
2(3)¼10.345*
3–6 90 (39.6) 137 (60.4)
7–10 56 (38.4) 90 (61.6)
11+ 37 (27.0) 100 (73.0)
Direct patient care per week
o20hrs 63 (38.0) 103 (62.0) w
2(1)¼0.694
20+hrs 127 (34.2) 244 (65.8)
Community size
o100000 12 (30.0) 28 (70.0) w
2(2)¼7.06
100000–500000 63 (34.8) 118 (65.2)
500000+ 115 (36.5) 200 (63.5)
d.f.¼degrees of freedom. *Po0.05, **Po0.01.
Table 6 Multivariate Logistic Regression predicting usual approach to
decision-making
Independent variables b (s.e.) Wald (v
2) (d.f.) AOR (95% CI)
Age 0.00 (0.14) w
2(1)¼0.00 1.00 (0.75–1.33)
Country of training
Australia 0.42 (0.30) w
2(1)¼1.98 1.52 (0.85–2.74)
Other
Caseload
0–2 w
2(3)¼11.33* 1—
3–6 0.53 (0.27) w
2(1)¼3.78 1.71 (1.00–2.92)
7–10 0.57 (0.29) w
2(1)¼3.74 1.77 (0.99–3.14)
411 1.03 (0.31) w
2(1)¼11.23** 2.81 (1.54–5.16)
Cancer specialty
Colorectal, gynaecology,
and haematological
Breast and urological 1.10 (0.19) w
2(1)¼33.94** 3.02 (2.08–4.37)
Gender
Male 1—
Female 0.63 (0.26) w
2(1)¼5.99* 1.87 (1.13–3.10)
AOR¼adjusted odds ratio; d.f.¼degrees of freedom; 95% CI¼95% confidence
interval. *Po0.05, **Po0.01.
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(Whitney et al, 2003), such as mastectomy vs breast conservation
or radical prostatectomy vs hormone therapy and brachytherapy
for prostate cancer. The surgical treatment options in breast cancer
may explain the higher proportion of surgeons (who have a clear
choice to offer) compared to medical oncologists (who may feel
that systemic therapy is definitely indicated) who reported sharing
decision-making with their patients. Similarly, colorectal, gynae-
cological oncologists, and haematologists may also feel that their
patients need more direction due to lack of treatment options
available. This interpretation is supported elsewhere with family
physicians asserting that SDM is most appropriate when clinical
equipoise exists (Elwyn et al, 2000; Whitney et al, 2003).
Respondents were not asked to identify a particular decision,
nor did the questionnaire stipulate that the questions should be
answered in contexts where equitable treatment options existed;
yet our results indicate that context and existence of equitable
treatment options may play a part in doctors’ comfort and
readiness to use SDM.
The consumer movement and public awareness of surgical
treatment options in breast and prostate cancer may also have
contributed to these results. The doctors in these specialties may
be responding to this shift, as their patients demand more
information and a role in discussing and deciding about treatment.
Breast and urological cancer doctors believe more of their patients
wish to be involved in decision-making. Indeed, studies that have
investigated the information and involvement preferences of
patients demonstrate that breast cancer patients prefer a more
active role than other cancer patients (Beaver et al, 1996; Degner
et al, 1997; Bruera et al, 2002).
Differences according to caseload in support of SDM may be
related to practice setting and multi-disciplinary relationships.
Doctors who treat fewer patients with a particular cancer may be
less comfortable with involving patients in decision-making due to
their reduced familiarity with treatment options. Those with a
large caseload are perhaps more likely to be a multi-disciplinary
team member where SDM is fostered, and more likely to feel
confident in offering a number of options.
Discrepancy between reported comfort levels and usual
practise
The discrepancy in the reporting of comfort with SDM and the use
of this approach in practice mirrors the Canadian results. For all
Table 7 Univariate analyses of high comfort levels with SDM
a
High comfort with SDM N (%) v
2 (d.f.)
Doctor type
Medical oncologists 105 (89.0) w
2(4)¼4.95
Radiation oncologists 39 (78.0)
Haematologists
b 4 (66.7)
Paediatric oncologists 9 (81.8)
Surgeons 296 (84.3)
Cancer specialty
Breast and urological 360 (87.6) w
2(1)¼12.74**
Colorectal, gynaecology
and haematology
93 (74.4)
Gender
Male 372 (83.0) w
2(2)¼4.56*
Female 81 (92.0)
Age
Under 40 years 65 (86.7) w
2(2)¼0.42
40–55 years 241 (83.4)
Over 55 years 146 (84.6)
Country of medical training
Australia 412 (84.4) w
2(1)¼0.00
Other 39 (84.8)
Caseload per month
2 or less 62 (81.6) w
2(3)¼6.65
3–6 162 (80.6) P¼0.084
7–10 111 (86.7)
11+ 113 (90.4)
Direct patient care per week
o20hrs 137 (82.5) w
2(1)¼0.70
20+hrs 315 (85.4)
Community size
o100000 34 (85.0) w
2(2)¼1.27
100000–500000 158 (86.8)
500000+ 259 (83.0)
*Po0.05 **Po0.01.
aPercentages here represent respondents who reported
comfort levels of 4 or 5 on the 5-point Likert scale, 1¼not comfortable, 5¼very
comfortable.
bAn initial decision to shorten the survey for participants other than
breast cancer specialists, excluding the question concerning comfort levels with each
of the four decision making examples was reversed mid-way through sending the
survey to second cohort (haematologists) and explains the small number of
responses in this group for these questions.
Table 8 Multivariate logistic regression predicting high comfort with
SDM
Independent variables b (s.e.) Wald (v
2) (d.f.) AOR (95% CI)
Cancer specialty
Colorectal, gynaecology,
and haematological
Breast and urological 0.93 (0.26) w
2(1)¼12.58** 2.53 (1.52–4.24)
Caseload
0–2
3–6 0.10 (0.35) w
2(1)¼0.80 1.11 (0.55–2.22)
7–10 0.56 (0.40) w
2(1)¼1.95 1.76 (0.80–3.88)
411 0.84 (0.43) w
2(1)¼3.82 2.33 (1.00–5.44)
Gender
Male 1–
Female 0.84 (0.42) w
2(1)¼3.97* 2.31 (1.01–5.27)
AOR¼adjusted odds ratio; d.f.¼degrees of freedom; 95% CI¼95% confidence
interval. *Po0.05, **Po0.01.
Table 9 Discrepancy between high comfort level and reported use of
SDM
Usual approach
N (%)
High level of
comfort N (%) Mismatch
Tumour type
Breast 202 (67.1) 266 (86.9) 19.8
Colorectal 36 (46.2) 51 (67.1) 20.9
Leukaemia/lymphoma 39 (47.0) 18 (81.8) 34.8
Gynaecological 11 (40.7) 24 (88.9) 48.2
Urological 84 (81.6) 94 (89.5) 7.9
Doctor type
Medical oncologists 91 (65.0) 105 (89.0) 24.0
Radiation oncologists 26 (50.0) 39 (78.0) 28.0
Haematologists 29 (47.5) 4 (66.7) 19.2
Paediatric oncologists 4 (28.6) 9 (81.8) 53.2
Surgeons 231 (69.2) 296 (84.3) 15.1
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ssurveyed clinicians except those treating colorectal cancer, over
80% reported high levels of comfort with SDM; yet, with the
exception of the breast and urological cohorts, less than 50%
reported using this approach for the majority of their patients.
Interpretation of this discrepancy affords varying standpoints.
Some commentators may interpret this discrepancy as evidence
that in certain oncology clinical situations choice does not exist
and therefore doctors would not use an SDM approach. Whitney
discusses the issue of no treatment as a non-viable option and cites
the example of a life-threatening gunshot wound and the
inappropriateness of SDM in this context. Yet in oncology, no
treatment could be seen as medically reasonable in many instances
where treatment reduces risk but does not eliminate it, and carries
serious side effects. This interpretation opens up the debate on
what constitutes a medically reasonable option and whether this
always includes intervention. More generally, however, these
criteria for SDM may be refuted by those who comment that
SDM is always appropriate even in circumstances where a
treatment choice is obvious, as patients need to be involved in
the decision to understand the logic. There may also be other
barriers to implementation of SDM, which we as yet do not
understand.
Similar discrepancies have been reported internationally.
General practitioners in the United Kingdom also professed
support for SDM but when their own consultations were analysed
the participating doctors agreed components of SDM did not occur
(Stevenson et al, 2000). Braddock et al (1999) analysed 1057
consultations of primary care physicians and surgeons in 1993 and
found that only 11.3% included discussion of alternative treatment
options and just 7.8% included pros and cons. An Australian study
in 2001 of consultations with advanced cancer patients showed
that only 27% of patients were offered a choice, and 44% were
given information on an alternative course of action to anticancer
therapy (Gattellari et al, 2002). In a Dutch study of advanced
cancer patient care, acknowledgement of the medical oncology
options of palliative chemotherapy or watchful waiting occurred in
half of the consultations, with just 27% receiving extensive
explanation of the watchful waiting option (Koedoot et al, 2004).
These results lead us to conclude that the discrepancy between
reported high comfort and actual SDM practice may be greater
than that our self-reported data shows. It is important to explore
barriers to implementation that might explain this discrepancy.
CONCLUSIONS
Despite SDM being lauded as the gold standard for treatment
options discussion and reported high levels of comfort with SDM,
Australian clinicians are not currently reporting that this is their
usual practice. Cancer specialty, clinician gender, and higher
caseload of new patients influence cancer doctors’ use of SDM.
Breast and urological cancer patients can expect a consultation
where their involvement and information preferences are more
likely to be explored. Clinician attitudes and use of SDM can be
influenced by the clinical situation in which they practice. Further
work is required to establish whether clinicians in cancers other
than breast and urological cancers recognise clinical scenarios
where they support and use SDM.
LIMITATIONS
A limitation of this study is the self-report nature of the survey;
therefore, we cannot verify whether participating clinicians
actually practise as they reported. There is the potential for social
desirability bias to have influenced the responses given by
participants, with participants reporting their usual practise to
be SDM knowing the patient-centred ethos of modern healthcare.
Finally, we asked doctors about their usual or general approach to
treatment decision-making. This did not allow them to indicate
how they would respond in different situations, although many
commented that they would vary their approach. Identification of
participants was undertaken through professional societies and
some eligible clinicians may not have received an invitation to
participate if they were not registered members of the professional
societies approached.
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